Home » NASTECH PHARMA ENTERS DEVELOPMENT DEAL WITH AMYLIN PHARMA
NASTECH PHARMA ENTERS DEVELOPMENT DEAL WITH AMYLIN PHARMA
Nastech Pharmaceutical Company Inc. entered a agreement with Amylin Pharmaceuticals, Inc. to develop a nasal spray formulation of exenatide. StreetInsider.com (http://www.streetinsider.com/news.php?id=988986&st=p)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May